India · Delayed Price · Currency is INR Medico Remedies Statistics
Total Valuation
Medico Remedies has a market cap or net worth of INR 3.62 billion. The enterprise value is 3.78 billion.
| Market Cap | 3.62B |
| Enterprise Value | 3.78B |
Important Dates
The last earnings date was Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Medico Remedies has 82.98 million shares outstanding. The number of shares has increased by 0.55% in one year.
| Current Share Class | 82.98M |
| Shares Outstanding | 82.98M |
| Shares Change (YoY) | +0.55% |
| Shares Change (QoQ) | +1.75% |
| Owned by Insiders (%) | 71.38% |
| Owned by Institutions (%) | 1.20% |
| Float | 22.02M |
Valuation Ratios
The trailing PE ratio is 26.35.
| PE Ratio | 26.35 |
| Forward PE | n/a |
| PS Ratio | 1.52 |
| PB Ratio | 4.80 |
| P/TBV Ratio | 4.80 |
| P/FCF Ratio | 261.81 |
| P/OCF Ratio | 61.71 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.78, with an EV/FCF ratio of 272.97.
| EV / Earnings | 27.36 |
| EV / Sales | 1.59 |
| EV / EBITDA | 20.78 |
| EV / EBIT | 25.26 |
| EV / FCF | 272.97 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 1.06 |
| Debt / FCF | 13.87 |
| Interest Coverage | 7.75 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 11.99% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 7.81% |
| Revenue Per Employee | 11.18M |
| Profits Per Employee | 648,587 |
| Employee Count | 213 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Medico Remedies has paid 51.50 million in taxes.
| Income Tax | 51.50M |
| Effective Tax Rate | 27.16% |
Stock Price Statistics
The stock price has increased by +6.28% in the last 52 weeks. The beta is 0.65, so Medico Remedies's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | +6.28% |
| 50-Day Moving Average | 42.40 |
| 200-Day Moving Average | 45.33 |
| Relative Strength Index (RSI) | 47.27 |
| Average Volume (20 Days) | 14,848 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medico Remedies had revenue of INR 2.38 billion and earned 138.15 million in profits. Earnings per share was 1.66.
| Revenue | 2.38B |
| Gross Profit | 582.90M |
| Operating Income | 149.63M |
| Pretax Income | 189.65M |
| Net Income | 138.15M |
| EBITDA | 181.91M |
| EBIT | 149.63M |
| Earnings Per Share (EPS) | 1.66 |
Balance Sheet
The company has 37.51 million in cash and 192.04 million in debt, with a net cash position of -154.53 million or -1.86 per share.
| Cash & Cash Equivalents | 37.51M |
| Total Debt | 192.04M |
| Net Cash | -154.53M |
| Net Cash Per Share | -1.86 |
| Equity (Book Value) | 754.75M |
| Book Value Per Share | 9.15 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 58.74 million and capital expenditures -44.90 million, giving a free cash flow of 13.85 million.
| Operating Cash Flow | 58.74M |
| Capital Expenditures | -44.90M |
| Depreciation & Amortization | 32.28M |
| Net Borrowing | -5.50M |
| Free Cash Flow | 13.85M |
| FCF Per Share | 0.17 |
Margins
Gross margin is 24.49%, with operating and profit margins of 6.29% and 5.80%.
| Gross Margin | 24.49% |
| Operating Margin | 6.29% |
| Pretax Margin | 7.97% |
| Profit Margin | 5.80% |
| EBITDA Margin | 7.64% |
| EBIT Margin | 6.29% |
| FCF Margin | 0.67% |
Dividends & Yields
Medico Remedies does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.55% |
| Shareholder Yield | -0.55% |
| Earnings Yield | 3.81% |
| FCF Yield | 0.38% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 16, 2023. It was a forward split with a ratio of 5.
| Last Split Date | Mar 16, 2023 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |